BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 38533551)

  • 1. Inhibitory protein-protein interactions of the SIRT1 deacetylase are choreographed by post-translational modification.
    Krzysiak TC; Choi YJ; Kim YJ; Yang Y; DeHaven C; Thompson L; Ponticelli R; Mermigos MM; Thomas L; Marquez A; Sipula I; Kemper JK; Jurczak M; Thomas G; Gronenborn AM
    Protein Sci; 2024 Apr; 33(4):e4938. PubMed ID: 38533551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Insulin-Responsive Sensor in the SIRT1 Disordered Region Binds DBC1 and PACS-2 to Control Enzyme Activity.
    Krzysiak TC; Thomas L; Choi YJ; Auclair S; Qian Y; Luan S; Krasnow SM; Thomas LL; Koharudin LMI; Benos PV; Marks DL; Gronenborn AM; Thomas G
    Mol Cell; 2018 Dec; 72(6):985-998.e7. PubMed ID: 30415949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. hMOF acetylation of DBC1/CCAR2 prevents binding and inhibition of SirT1.
    Zheng H; Yang L; Peng L; Izumi V; Koomen J; Seto E; Chen J
    Mol Cell Biol; 2013 Dec; 33(24):4960-70. PubMed ID: 24126058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carboxamide SIRT1 inhibitors block DBC1 binding via an acetylation-independent mechanism.
    Hubbard BP; Loh C; Gomes AP; Li J; Lu Q; Doyle TL; Disch JS; Armour SM; Ellis JL; Vlasuk GP; Sinclair DA
    Cell Cycle; 2013 Jul; 12(14):2233-40. PubMed ID: 23892437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of deleted in breast cancer 1 (DBC1) protein in SIRT1 deacetylase activation induced by protein kinase A and AMP-activated protein kinase.
    Nin V; Escande C; Chini CC; Giri S; Camacho-Pereira J; Matalonga J; Lou Z; Chini EN
    J Biol Chem; 2012 Jul; 287(28):23489-501. PubMed ID: 22553202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DBC1 phosphorylation by ATM/ATR inhibits SIRT1 deacetylase in response to DNA damage.
    Zannini L; Buscemi G; Kim JE; Fontanella E; Delia D
    J Mol Cell Biol; 2012 Oct; 4(5):294-303. PubMed ID: 22735644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deleted in breast cancer 1 (DBC1) protein regulates hepatic gluconeogenesis.
    Nin V; Chini CC; Escande C; Capellini V; Chini EN
    J Biol Chem; 2014 Feb; 289(9):5518-27. PubMed ID: 24415752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deleted in breast cancer-1 regulates SIRT1 activity and contributes to high-fat diet-induced liver steatosis in mice.
    Escande C; Chini CC; Nin V; Dykhouse KM; Novak CM; Levine J; van Deursen J; Gores GJ; Chen J; Lou Z; Chini EN
    J Clin Invest; 2010 Feb; 120(2):545-58. PubMed ID: 20071779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel form of Deleted in breast cancer 1 (DBC1) lacking the N-terminal domain does not bind SIRT1 and is dynamically regulated in vivo.
    Santos L; Colman L; Contreras P; Chini CC; Carlomagno A; Leyva A; Bresque M; Marmisolle I; Quijano C; Durán R; Irigoín F; Prieto-Echagüe V; Vendelbo MH; Sotelo-Silveira JR; Chini EN; Badano JL; Calliari AJ; Escande C
    Sci Rep; 2019 Oct; 9(1):14381. PubMed ID: 31591441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of SIRT1 activity by genotoxic stress.
    Yuan J; Luo K; Liu T; Lou Z
    Genes Dev; 2012 Apr; 26(8):791-6. PubMed ID: 22465953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chk2 and REGγ-dependent DBC1 regulation in DNA damage induced apoptosis.
    Magni M; Ruscica V; Buscemi G; Kim JE; Nachimuthu BT; Fontanella E; Delia D; Zannini L
    Nucleic Acids Res; 2014 Dec; 42(21):13150-60. PubMed ID: 25361978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDAC3 is negatively regulated by the nuclear protein DBC1.
    Chini CC; Escande C; Nin V; Chini EN
    J Biol Chem; 2010 Dec; 285(52):40830-7. PubMed ID: 21030595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SIRT7 promotes thyroid tumorigenesis through phosphorylation and activation of Akt and p70S6K1 via DBC1/SIRT1 axis.
    Li H; Tian Z; Qu Y; Yang Q; Guan H; Shi B; Ji M; Hou P
    Oncogene; 2019 Jan; 38(3):345-359. PubMed ID: 30093629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative regulation of the deacetylase SIRT1 by DBC1.
    Zhao W; Kruse JP; Tang Y; Jung SY; Qin J; Gu W
    Nature; 2008 Jan; 451(7178):587-90. PubMed ID: 18235502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Expression of SIRT1 and DBC1 in Laryngeal and Hypopharyngeal Carcinomas.
    Yu XM; Liu Y; Jin T; Liu J; Wang J; Ma C; Pan XL
    PLoS One; 2013; 8(6):e66975. PubMed ID: 23805287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylation in the regulation of autophagy.
    Xu Y; Wan W
    Autophagy; 2023 Feb; 19(2):379-387. PubMed ID: 35435793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MCC inhibits beta-catenin transcriptional activity by sequestering DBC1 in the cytoplasm.
    Pangon L; Mladenova D; Watkins L; Van Kralingen C; Currey N; Al-Sohaily S; Lecine P; Borg JP; Kohonen-Corish MR
    Int J Cancer; 2015 Jan; 136(1):55-64. PubMed ID: 24824780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reciprocal roles of DBC1 and SIRT1 in regulating estrogen receptor α activity and co-activator synergy.
    Yu EJ; Kim SH; Heo K; Ou CY; Stallcup MR; Kim JH
    Nucleic Acids Res; 2011 Sep; 39(16):6932-43. PubMed ID: 21596782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of DBC1 by SUMO2/3 is crucial for p53-mediated apoptosis in response to DNA damage.
    Park JH; Lee SW; Yang SW; Yoo HM; Park JM; Seong MW; Ka SH; Oh KH; Jeon YJ; Chung CH
    Nat Commun; 2014 Nov; 5():5483. PubMed ID: 25406032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DBC1 is a negative regulator of SIRT1.
    Kim JE; Chen J; Lou Z
    Nature; 2008 Jan; 451(7178):583-6. PubMed ID: 18235501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.